Translational exploration preparing program causes understudies to more readily comprehend patients’ issues Kumar Jeetendra | September 27, 2020 Translational research aims to speed research breakthroughs into the practice. And yet, training for basic scientists and clinicians too often remains siloed, resulting in divergent cultures and a lack of chance for cross-disciplinary collaboration. The South Carolina Clinical & Translational Research (SCTR) Institute’s TL1 application, a translational research training program for doctoral students in the …
Parkinson’s disease is a free danger factor for biting the dust from COVID-19, study recommends Kumar Jeetendra | October 3, 2020 A fresh study of about 80,000 patients shows that people with Parkinson’s disease (PD) have a 30% greater risk of dying from COVID-19 than individuals without the neurodegenerative condition. The new analysis conducted by researchers at University of Iowa Health Care based on patient information in the TriNetX COVID-19 research network suggests that Parkinson’s disease …
New nasal spray conveys antipsychotic medicine straightforwardly to the brain Kumar Jeetendra | January 17, 2021 A team of neuroscientists and engineers at McMaster University has made a nasal spray to deliver antipsychotic medication directly to the mind rather than having it pass through the body. The jump in efficiency means patients with schizophrenia, bipolar disorder and other conditions could see their doses of powerful antipsychotic drugs cut by as much …
Protein alteration adds to degeneration of neuronal populaces in Huntington’s infection Kumar Jeetendra | February 1, 2021 A study in which UB scientists have taken part states that alterations in the levels of one of those proteins, lamin B1, add to the degeneration of distinct brain neuronal populations in Huntington’s disease. Caused by a mutation in the huntingtin gene, this pathology features involuntary movements, cognitive deficit, and psychiatric disorders, and has no …
